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Abstract
Background: Cardiopulmonary exercise testing (CPET) has become increasingly important as a
routine procedure in daily clinical work. So far, it is generally accepted that an individualized
exercise protocol with exercise duration of 6 to 12 minutes is preferable to assess maximal
exercise performance. The aim of this study was to compare an individualized NYHA adapted
exercise protocol with a fixed standard protocol in patients with severe pulmonary arterial
hypertension.
Methods: Twenty-two patients (17 female, 5 male; mean age 49 ± 14 yrs) underwent symptom
limited CPET on a bicycle. On two consecutive days each subject performed a stepwise CPET
according to a modified Jones protocol (16 Watt per minute stages) as well as an individualized
NYHA adapted protocol with 5 or 10 Watt/min stages in a randomized order. Oxygen uptake at
peak exercise (peakVO2) and anaerobic threshold (VO2AT), maximal ventilation (VE), breathing
reserve (VE/MVV), ventilatory efficiency (VE vs. VCO2 slope), exercise time, maximal power and
work rate were assessed and compared between both protocols.
Results: Comparing both, adapted NYHA protocol and standardized Jones protocol, we found
significant differences in maximal power (56.7 ± 19 W vs. 74 ± 18 W; p < 0.001) and exercise time
(332 ± 107 sec. vs. 248 ± 72 sec.; p < 0.001). In contrast, no significant differences were obvious
comparing both protocols concerning work rate, VE, VE/MVV, peakVO2, VO2AT and VE vs. VCO2
slope.
Conclusion: Variations of incremental step size during CPET significantly affect exercise time and
maximal power, whereas relevant parameters for clinical judgement and prognosis such as oxygen
uptake, ventilation and ventilatory efficiency remain unchanged. These findings have practical
implications for the exercise evaluation of patients with pulmonary hypertension. To reach maximal
results for ventilation, oxygen uptake and gas exchange an individualization of incremental step size
appears not to be mandatory.
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Backround
Cardiopulmonary exercise testing (CPET) has become
increasingly important as a routine procedure in daily
clinical work. It has been applied to patients with chronic
congestive heart failure for risk stratification [1] and to
assess responses to therapeutic interventions [2-5].
Parameters such as oxygen uptake at anaerobic threshold
(VO2AT) and at peak exercise (peakVO2) are powerful pre-
dictors for survival in patients with advanced congestive
heart failure [6]. Recently, its importance has been wid-
ened to patients suffering from severe pulmonary hyper-
tension and right heart failure [7]. In addition to oxygen
uptake related parameters, the characterization of ventila-
tory efficiency, usually expressed as the relation of minute
ventilation to carbon dioxide output (VE vs. VCO2 slope),
has become increasingly important due to its prognostic
and therapeutic implications [8,9].
So far, it is generally accepted that an individualized exer-
cise protocol is preferable to assess maximal exercise per-
formance. Wasserman and colleagues introduced ramp or
1-minute incremental exercise tests with an "optimal"
exercise duration of 6 to 12 minutes [10]. Therefore, an
individualization of the increments in work rate is sup-
posed to be mandatory in CPET to achieve optimal results
for parameters of peakVO2 as well as ventilatory parame-
ters.
The aspired individualization of the exercise protocol
however, complicates the use of CPET in daily routine.
The postulation of exercise durations between 6 and 12
minutes is mainly based on studies that investigated small
groups of healthy volunteers [11-13]. There are concerns
about the transfer of these results to patients suffering
from pulmonary or cardiac diseases. Myers et al. found
differences in parameters of peakVO2 in healthy subjects
with different exercise protocols. However, they could not
show this dependence in a small group of patients with
congestive heart failure (CHF) [14]. In addition, the need
of protocol individualization has to be debated in view of
the data by Debigare et al. [15]. In this study the results of
CPET were independent of different protocol designs in a
group of 10 patients suffering on chronic obstructive pul-
monary disease (COPD).
The aim of this study was to compare an individualized
NYHA adapted exercise protocol with a fixed standard
protocol in patients with severe pulmonary hypertension
and right heart failure using a randomized protocol. The
investigators hypothesized that there are no differences
between the individualized to the "one-protocol-fits all"
approach.
Methods
Study subjects
Seventeen female (mean age 46.9 ± 12.7 yrs) and five
male (mean age 57.47 ± 15.1 yrs) subjects volunteered to
participate in the investigation. All patients suffering from
pulmonary arterial hypertension (WHO Group I [16]).
Only patients with primary pulmonary hypertension were
included. The mean systolic pulmonary artery pressure
(PAP), estimated by echocardiography, was 68 mmHg ±
35 mmHg. No patients had echocardiographical evidence
for a relevant left heart failure or underlying valvular dis-
ease. All patients were clinically assessed as NYHA/WHO
class II (n = 10) or III (n = 12). They had to be clinically
stable for at least 4 weeks prior to inclusion and continued
their chronic medication. This targeted therapy included
inhaled Iloprost (n = 5), Bosentan (n = 18), Sitaxsentan (n
= 2), Sildenafil (n = 5), or Tadalafil (n = 2). In 11 patients
combinations of these substances were given. None of the
patients was on oxygen therapy at home.
The study protocol was approved by the Ethics Committee
of the University of Greifswald. All subjects gave informed
written comment.
Exercise testing
Each subject performed two exercise tests in randomized
order on two consecutive days. Consecutive patients were
randomized to either protocol sequence in a one-to-one
order. All subjects were requested to abstain from food,
coffee and cigarette smoking for at least 3 hours prior to
the test. All patients were assessed during there first clini-
cal evaluation and were naïve to CPET.
The following bicycle tests were employed:
1. a symptom limited exercise test according to the Jones
protocol [17] (stepwise increase in work load of 16 Watt/
minute, starting with unloaded cycling plus the ergometer
related permanent load)
2. a symptom limited exercise test according to an adapted
NYHA protocol [10,18,19].
a. Protocol NYHA II: ramp test with an increase in work
load of 10 Watt per minute, starting with unloaded
cycling plus the ergometer related permanent load.
b. Protocol NYHA III: ramp test with an increase in work
load of 5 Watt per minute, starting with unloaded cycling
plus the ergometer related permanent load.
The assignment to either NYHA II or III protocol occurred
according to clinical classification.BMC Pulmonary Medicine 2008, 8:3 http://www.biomedcentral.com/1471-2466/8/3
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Each protocol was preceded by a resting period of at least
3 minutes to reach steady state conditions (steady state
status was analyzed for VO2, VCO2, VE, EQO2/CO2,
PETO2/CO2).
In the absence of chest pain, ECG abnormalities, complex
arrhythmias or critical blood pressure changes all tests
were continued as symptom limited (volitional exertion,
dyspnoea or fatigue). Prior to the test patients were
encouraged to reach maximal exhaustion, while during
exercise no further motivational interventions were
obtained. The protocol type was employed in a blinded
fashion to the patient. After the test patients were asked to
state the reasons for termination.
All tests were applied according to current guidelines for
exercise testing [20] with continuous monitoring of ECG,
blood pressure and oxygen saturation. All tests were per-
formed at room air.
Gas exchange variables
Respiratory gas exchange variables were measured contin-
uously throughout the resting period, the unloaded
cycling period and the exercise test using a VIASYS
HEALTHCARE system (Oxycon Pro, Rudolph's mask.
Prior to each test, the equipment was calibrated in stand-
ard fashion with reference gas and volume calibration.
Standard 12-lead ECGs were obtained at rest, every
minute during exercise, and for at least 5 minutes during
recovery; blood pressure was measured with a standard
cuff sphygmomanometer. Minute ventilation (VE), tidal
volume (Vt), oxygen uptake (VO2) and carbon dioxide
output (VCO2) were acquired on a breath-by-breath basis
and averaged over 10 second intervals. Peak oxygen
uptake (peak VO2) was defined as the highest 10-s average
of oxygen uptake in the last minute of exercise. Ventilatory
efficiency, expressed as the relation of VE and VCO2, has
been assessed as the slope of the regression of both
parameters excluding excess hyperventilation at the end of
exercise. Previous work by our group and others has
shown that this method of calculating the VE vs. VCO2
slope is prognostically optimal [1,3,8,21,22]. The anaero-
bic threshold was determined by two independent experi-
enced observers in a blinded fashion according to
Wasserman et al. [10]. The breathing reserve (VE/MVV)
was calculated as maximal ventilation (VE) in relation to
maximal voluntary ventilation (MVV). MVV was calcu-
lated by FEV1 × 41.
On maximal exercise we assessed the maximal power in
Watt as shown by the bicycle ergometer; work rate was
assessed by the product of exercise time and maximal
power in Joule (J).
Statistical analysis
All statistical analyses were performed with SPSS software,
version 14.0.1 (SPSS GmbH Software, Munich, Ger-
many). The means ± standard deviations (SD) and the
confidence intervals of the means were calculated for
peakVO2, VO2AT, VE, VE/MVV, maximal power, work
rate, exercise time and VE vs. VCO2 slope. Paired sample t
test was used to determine whether there was a significant
difference between the means generated under two differ-
ent exercise protocols. P values ≤ 0.05 were defined as sta-
tistically significant.
Results
In the study population 10 patients were assigned to the
protocol NYHA II, 12 to the protocol NYHA III. According
to the randomization sequence an equal split for either
starting with the NYHA or Jones protocol was reached.
There were no significant differences comparing day 1 and
day 2 CPET regarding peakVO2 (938 ± 190 vs. 934 ± 192
ml/min) and VO2AT (633 ± 108 vs. 620 ± 108 ml/min).
In two patients assigned to NYHA III protocol the anaero-
bic threshold could not be determined neither by the
NYHA nor by the Jones protocol procedure according to
the criteria mentioned above. In all other cases the calcu-
lation of the anaerobic threshold was supported by at least
two corresponding methods. Significant differences
between NYHA and Jones protocol procedures were obvi-
ous for exercise time and maximal power. No significant
differences were found for parameters describing exercise
performance (peakVO2 and VO2AT), ventilation on exer-
cise (maximal VE, VE/MVV) as well as ventilatory effi-
ciency (VE vs. VCO2 slope) (see Table 1, 2 and Figures 1,
2, 3). Comparing the CPET according to the Jones proto-
col to the corresponding NYHA II and III subgroup again
no significant differences were obvious for peakVO2,
VO2AT, VE vs. VCO2 slope, maximal VE and VE/MVV.
Reasons for terminating exercise were dyspnoea in 16
patients (including all patients assessed as NYHA class III)
and dyspnoea in addition to general fatigue in 6 patients.
The reason for terminating exercise did not differ between
day 1 and 2 in any patient. All tests were performed symp-
tom limited, no premature termination by the investiga-
tor occurred.
Discussion
Aim of the study was to compare different exercise proto-
cols in patients suffering from significant cardiac limita-
tions due to pulmonary hypertension. Currently, the need
of an individualized exercise protocol to reach exercise
durations between 6 and 12 minutes is generally accepted.
In daily practice, protocols according to the recommenda-
tions of Wasserman et al. [10] are widely used to reach
exercise durations between 6 and 12 minutes. These rec-
ommendations are mainly based on data obtained inBMC Pulmonary Medicine 2008, 8:3 http://www.biomedcentral.com/1471-2466/8/3
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healthy volunteers [11-13], however, the necessary calcu-
lations providing individually adjusted exercise protocols
complicate the daily routine of this method.
Data by Myers et al. collected within a small group of CHF
patients comparing different exercise protocols (cycle
ergometry), show ignorable differences for prognostically
and clinically relevant parameters such as peakVO2 and
VO2AT [14]. Debigare et al. showed comparable results in
a small group of COPD patients.
Similarly, our data did not show a major impact of the
exercise protocol design on peakVO2  and VO2AT in
patients suffering from pulmonary hypertension. Com-
paring the results for day 1 and day 2 exercise tests signif-
icant differences concerning oxygen uptake and therefore
exercise tolerance were not seen. Thus, we assume an
ignorable influence of the previous test onto the following
procedure. In addition, ventilatory efficiency – as
expressed as VE vs. VCO2 slope – was not affected by dif-
ferent exercise protocols. Therefore, the majority of clini-
cal and prognostic parameters with relevance to patients
with severe cardiac limitations were independent of differ-
ent exercise protocol designs.
Changes in exercise duration and maximal power output
are related to the size of the incremental steps used in var-
ious exercise protocols.
An increasing step size is physiologically accompanied by
shorter exercise durations and higher maximal work
loads. Maximal work load, exercise duration and power
however, are not related to prognosis in patients with pul-
monary hypertension in a multivariate analysis [23].
Comparing both protocols (NYHA and Jones) we did not
find differences in the quality of anaerobic threshold
VE vs. VCO2 slope assessed by NYHAII/III protocol and the  Jones protocol indicated as mean, interquartile range and  97.5 confidence interval Figure 3
VE vs. VCO2 slope assessed by NYHAII/III protocol and the 
Jones protocol indicated as mean, interquartile range and 
97.5 confidence interval. n.s. for missing significance. 95% 
confidence interval for the difference of variables was -4.6 – 
7.4.
PeakVO2 (ml/min) assessed by NYHAII/III protocol and the  Jones protocol indicated as mean, interquartile range and  97.5 confidence interval Figure 1
PeakVO2 (ml/min) assessed by NYHAII/III protocol and the 
Jones protocol indicated as mean, interquartile range and 
97.5 confidence interval. n.s. for missing significance. 95% 
confidence interval for the difference of variables was -84.7 – 
98.8.
VO2AT(ml/min) assessed by NYHAII/III protocol and the  Jones protocol indicated as mean, interquartile range and  97.5 confidence interval Figure 2
VO2AT(ml/min) assessed by NYHAII/III protocol and the 
Jones protocol indicated as mean, interquartile range and 
97.5 confidence interval. n.s. for missing significance. 95% 
confidence interval for the difference of variables was -37.2 – 
70.3.BMC Pulmonary Medicine 2008, 8:3 http://www.biomedcentral.com/1471-2466/8/3
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determination using the methods introduced by Wasser-
man et al. Even though this study was not designed to
evaluate this topic we completely agree with the need of
one minute incremental steps or continuous progression
of protocols with respect to the quality of anaerobic
threshold determination. The exercise duration as well as
the exercise protocol did not influence the reproducibility
of the anaerobic threshold determination.
Corresponding to the results of oxygen uptake und venti-
latory efficiency in relation to the exercise protocol used
ventilatory parameters such as maximal ventilation and
breathing reserve remained unaffected by the choice of
protocol. Although our study was not conducted to evalu-
ate patients with significant ventilatory limitations these
observations correspond to the results published by oth-
ers [11,12,14,15].
Our study has several limitations. First, we decided to
compare a limited number of protocols in a well defined
group of patients. Whether these results can be applied to
other protocol designs and to patients with other than car-
diac limitations remains to be shown. Second, the exercise
time in the NYHA adapted tests did not reach the currently
recommended lower limit of 6 minutes in all cases. There-
fore, the expected exercise capacity had been overesti-
mated by the NYHA adaptation in a number of patients.
We assume however, that this problem is also common in
daily clinical work. Finally, the number of patients limits
the study in its power. By obvious technical reasons as
well as in agreement with the approval by the ethics com-
mittee the study was undergone in a single blinded fash-
ion resulting in a blinding to the patient. However, the
resulting bias was minimized by the commitment to
encourage the patients only prior to exercise in always the
same way.
Conclusion
To our knowledge, these are the first data prospectively
comparing two different exercise protocols in a relevant
number of patients with severe cardiac limitation due to
pulmonary hypertension. Focusing on the clinically and
prognostically relevant parameters of oxygen uptake at
anaerobic threshold and peak exercise as well as on venti-
latory efficiency we did not find relevant differences. In
conclusion, using a uniform exercise protocol with one
Table 1: Comparison of Jones and NYHA CPET protocol for the entire groups*
Protocol Mean ± SD
Resting blood pressure [mmHg] systolic/diastolic NYHA (II/III) 111 ± 28.3/80.5 ± 6.4 p < 0.001
Jones 120.5 ± 24/85.5 ± 12
Peak blood pressure [mmHg] systolic/diastolic NYHA (II/III) 120 ± 27/73 ± 21 n.s.
Jones 130.4 ± 21/78 ± 17
Heart rate at rest [1/min] NYHA (II/III) 87.1 ± 11.7
Jones 88.7 ± 10.4 n.s.
Peak heart rate [1/min] NYHA (II/III) 128.2 ± 22.6
Jones 128.7 ± 19.2 n.s.
SaO2 [%] at rest NYHA (II/III) 95 ± 6
Jones 96 ± 5.5 n.s.
Peak SaO2 [%] NYHA (II/III) 88 ± 6.4
Jones 86 ± 6.9 n.s.
*Mean and standard deviation [SD]. n.s. for missing significance. SaO2 for arterial oxygen saturation measured by oxymetry.
Table 2: Comparison of Jones and NYHA CPET protocol for the entire groups*
Protocol Mean ± SD [95% CI's]
Maximal power [W] NYHA (II/III) 56.77 ± 18.98 [10.9–24.6]
Jones 74.55 ± 18.25 p < 0.001
Work rate [J] NYHA (II/III) 14566.48 ± 8241.8 [-5450.4 – 639.3]
Jones 12160.9 ± 5694.8 n.s.
Exercise time [sec.] NYHA (II/III) 332 ± 107 p < 0.001
Jones 248 ± 73
VE [l] NYHA (II/III) 48.5 ± 14.9 [-2.7 – 4.1]
Jones 49.23 ± 16.1 n.s.
VE/MVV NYHA (II/III) 0.567 ± 0.21 [-0.03 – 0.06]
Jones 0.58 ± 0.23 n.s.
*Mean and standard deviation [SD] and 95% confidence intervals [CI's] for the differences between both groups. n.s. for missing significance.BMC Pulmonary Medicine 2008, 8:3 http://www.biomedcentral.com/1471-2466/8/3
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minute incremental steps based on Jones et al. appears to
be sufficient in these patients. Concerning these parame-
ters an individual protocol adaptation is not superior to a
simplified approach.
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